Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot studyFilip Van den Bosch, Eric Veys|Annals of the Rheumatic Diseases|2000Cited by 292